Clinical usefulness of D-dimer in cancer patients with suspected pulmonary embolism Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003
Influence of cancer diagnosis in patients with pulmonary embolism Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020
Does D-dimer levels on admission predicts venous thromboembolism in patients with COVID-19? Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021
Efficacy of age adjusted d-dimer in excluding pulmonary embolism in patients with cancer. Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020
Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018
Does platelet index examination provide clinical benefit in coexistence of pulmonary thromboembolism and cancer? Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020
Pulmonary thromboembolism in patients with fibrotic lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 356s Year: 2006
Evaluation of cancer-associated thrombosis risk in patients with lung adenocarcinoma using the COMPASS-CAT risk assessment model Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021
Risk quantification for postoperative pulmonary complications after pulmonary resection in lung cancer patients Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients Year: 2008
Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018
Reasons for late diagnostics of lung cancer in pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012
Five cases of breast cancer complicated with pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 45s Year: 2006
Comparison of three clinical probability methods among patients with suspected pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Venous thromboembolism in lung cancer with clinical analysis of 89 cases Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012
Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021
Effect of statin therapy in patients with lung cancer on mortality, incidence of infections and pulmonary embolism Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Histology of lung cancer and pulmonary embolism. Are they related? Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021
How to identify patients with low risk pulmonary embolism Source: Eur Respir J 2007; 30: Suppl. 51, 603s Year: 2007
Pulmonary function testing in patients with lung cancer Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012
Silent venous thromboembolism (VTE) in patients undergoing thoracic surgery in the course of lung cancer. Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017